Resztak, M., Zalewska, P., Wachowiak, J., Sobkowiak-Sobierajska, A., & Główka, F. K. (2024). Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections. European Journal of Clinical Pharmacology, 80(11), 1829-1840. https://doi.org/10.1007/s00228-024-03752-z
Chicago-referens (17:e uppl.)Resztak, Matylda, Paulina Zalewska, Jacek Wachowiak, Agnieszka Sobkowiak-Sobierajska, och Franciszek K. Główka. "Voriconazole Therapeutic Drug Monitoring Including Analysis of CYP2C19 Phenotype in Immunocompromised Pediatric Patients with Invasive Fungal Infections." European Journal of Clinical Pharmacology 80, no. 11 (2024): 1829-1840. https://doi.org/10.1007/s00228-024-03752-z.
MLA-referens (9:e uppl.)Resztak, Matylda, et al. "Voriconazole Therapeutic Drug Monitoring Including Analysis of CYP2C19 Phenotype in Immunocompromised Pediatric Patients with Invasive Fungal Infections." European Journal of Clinical Pharmacology, vol. 80, no. 11, 2024, pp. 1829-1840, https://doi.org/10.1007/s00228-024-03752-z.
